PATENT CLAIM ANALYSIS

Application Number: 15878767
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "171000"]

Abstract:
Provided herein is an ophthalmic composition including a therapeutic active agent and an anti-inflammatory agent, in which the active agent is at least about 0.01% w/v of chlorhexidine, derivatives, or analogues of chlorhexidine, or a pharmaceutically acceptable salt, solvent, hydrate, or polymorph thereof. Methods for treating or preventing ocular disease or infection in a subject in need thereof are also provided. The method may include administering to an eye of a subject an ophthalmic composition including chlorhexidine, derivatives, or analogues of chlorhexidine, or a pharmaceutically acceptable salt, solvent, hydrate, or polymorph thereof, and an anti-inflammatory agent. The chlorhexidine, derivatives, or analogues of chlorhexidine, or a pharmaceutically acceptable salt, solvent, hydrate, or polymorph thereof and the anti-inflammatory agent are present in an amount effective to treat or prevent the ocular disease or infection in a subject in need thereof.

Claim (Index 26):
The method of  claim 15 , wherein the anti-inflammatory agent comprises a steroidal anti-inflammatory or a non-steroidal anti-inflammatory agent or both.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 86.0
- Lexical Diversity: 2.71667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15587764', '15667033', '11636293', '15200960', '11962324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7887984488960693
- 35 USC 102 Novelty (BERT): 0.5506324600086941
- Combined Prediction Score: 0.7649818500073319
- Mean Citation Score: 274.73686000000004
- Max Citation Score: 407.00012
- Similarity Product: 307.4073059928608

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test